- World rank, all time
- #15,108 of 42,892
- Rank in United States
- #3,300 of 8,685
- Research works
- 178 ▲ 47% vs 2013–17
- Citations
- 10k 59.0 per fractional work
- Top-10% rate
- 14.2% record average 16.5%
- Open access
- 42% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.1×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 11.1×
- Biochemistry, Genetics and Molecular Biology 5.0×
- Medicine 3.1×
- Veterinary 1.4×
- Immunology and Microbiology 1.3×
- Chemistry 0.8×
- Materials Science 0.4×
- Mathematics 0.3×
- Health Professions 0.3×
- Economics, Econometrics and Finance 0.2×
- Computer Science 0.2×
- Psychology 0.1×
- Engineering 0.1×
- Decision Sciences 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.0×
Who are the top researchers at Agios Pharmaceuticals (United States)?
Ranked on the composite score, Bin Wu, Katharine Yen and Marion Dorsch lead among researchers whose main affiliation is Agios Pharmaceuticals (United States).
- 1 Bin Wu United States · #125,243 worldwide 306 citations · 21 works
- 2 Katharine Yen United States · #155,644 worldwide 349 citations · 19 works
- 3 Marion Dorsch United States · #570,605 worldwide 68 citations · 16 works
- 4 Stefan Größ United States · #796,594 worldwide 13 citations · 17 works
- 5 Lenny Dang United States · #1,154,364 worldwide 41 citations · 16 works
- 6 Erin Zagadailov United States · #1,507,405 worldwide 7 citations · 15 works
Which keywords describe research at Agios Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Erythropoiesis, Ion Channels, Mechanotransduction, Apoptosis, Piezo1, Piezo2, Anemia and Sickle-cell Disease.
- Tumor Microenvironment
- Newborn Screening
- Iron Regulation
- Cytochrome P450
- Cancer
- Blood Groups
- Pancreatic Cancer
- Erythropoiesis-Stimulating Agents
- Neuroprotection
- Neutropenia
- Congenital Disorders
- Acute Myeloid Leukemia
- Prognostic Factors
- Cardiovascular Disease
- Iron Deficiency
- Thalassemia
- Epidemiology
- Piezo2
- Mechanotransduction
- Ion Channels
- Erythropoiesis
- Apoptosis
- Piezo1
- Anemia
- Sickle-cell Disease
- Hematopoietic Stem Cells
- Inflammation
- Genetic Mutations
- AML
- Chronic Kidney Disease
- Heart Failure
- Oxidative Stress
- Stroke
- Hypoxia-Inducible Factors
- Alloimmunization
- Pharmacokinetics
- Genetic Variants
- Hepcidin
- Drug Metabolism
- Pharmacogenetics
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Erythropoiesis7▲ 281×2 topics
- Ion Channels6▲ 131×3 topics
- Apoptosis6▲ 46×2 topics
- Mechanotransduction6▲ 213×2 topics
- Piezo16▲ 645×1 topic
- Piezo26▲ 645×1 topic
- Anemia6▲ 133×4 topics
- Epidemiology5▲ 3.1×2 topics
- Sickle-cell Disease5▲ 287×1 topic
- Thalassemia5▲ 287×1 topic
- Hematopoietic Stem Cells5▲ 124×2 topics
- Iron Deficiency3▲ 152×2 topics
- Inflammation3▲ 3.0×13 topics
- Cardiovascular Disease2▲ 5.1×4 topics
- Genetic Mutations2▲ 13×4 topics
- Prognostic Factors2▲ 13×3 topics
- AML2▲ 114×1 topic
- Acute Myeloid Leukemia2▲ 114×1 topic
- Chronic Kidney Disease2▲ 23×2 topics
- Congenital Disorders2▲ 362×1 topic
- Heart Failure2▲ 13×3 topics
- Neutropenia2▲ 362×1 topic
- Oxidative Stress2▲ 3.2×7 topics
- Neuroprotection2▲ 14×3 topics
- Stroke2▲ 27×2 topics
- Erythropoiesis-Stimulating Agents2▲ 377×1 topic
- Hypoxia-Inducible Factors2▲ 377×1 topic
- Pancreatic Cancer2▲ 39×2 topics
- Alloimmunization2▲ 173×1 topic
- Blood Groups2▲ 173×1 topic
- Pharmacokinetics2▲ 16×2 topics
- Cancer2▲ 2.8×9 topics
- Genetic Variants2▲ 21×3 topics
- Cytochrome P4501▲ 89×2 topics
- Hepcidin1▲ 80×1 topic
- Iron Regulation1▲ 80×1 topic
- Drug Metabolism1▲ 107×1 topic
- Newborn Screening1▲ 54×2 topics
- Pharmacogenetics1▲ 146×1 topic
- Tumor Microenvironment1▲ 6.0×5 topics
Which research topics does Agios Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Erythrocyte Function and Pathophysiology, Hemoglobinopathies and Related Disorders, Acute Myeloid Leukemia Research and Blood disorders and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Erythrocyte Function and Pathophysiology Physiology 6 works
- 2 Hemoglobinopathies and Related Disorders Genetics 5 works
- 3 Acute Myeloid Leukemia Research Hematology 2 works
- 4 Blood disorders and treatments Genetics 2 works
- 5 Erythropoietin and Anemia Treatment Hematology 2 works
- 6 Blood groups and transfusion Hematology 2 works
- 7 Iron Metabolism and Disorders Hematology 1 works
- 8 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
- 9 Hemoglobin structure and function Cell Biology 1 works
- 10 Genomics and Rare Diseases Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Agios Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 47% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.